Annual Total Liabilities
$660.79 M
+$89.07 M+15.58%
31 December 2023
Summary:
Esperion Therapeutics annual total liabilities is currently $660.79 million, with the most recent change of +$89.07 million (+15.58%) on 31 December 2023. During the last 3 years, it has risen by +$211.40 million (+47.04%). ESPR annual total liabilities is now at all-time high.ESPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$684.32 M
-$12.22 M-1.75%
30 September 2024
Summary:
Esperion Therapeutics quarterly total liabilities is currently $684.32 million, with the most recent change of -$12.22 million (-1.75%) on 30 September 2024. Over the past year, it has increased by +$53.01 million (+8.40%). ESPR quarterly total liabilities is now -1.75% below its all-time high of $696.54 million, reached on 30 June 2024.ESPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.6% | +8.4% |
| 3 y3 years | +47.0% | +16.4% |
| 5 y5 years | +927.1% | +266.4% |
ESPR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +47.0% | -1.8% | +19.7% |
| 5 y | 5 years | at high | +927.1% | -1.8% | +266.4% |
| alltime | all time | at high | >+9999.0% | -1.8% | >+9999.0% |
Esperion Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $684.32 M(-1.8%) |
| June 2024 | - | $696.54 M(+4.4%) |
| Mar 2024 | - | $667.36 M(+1.0%) |
| Dec 2023 | $660.79 M(+15.6%) | $660.79 M(+4.7%) |
| Sept 2023 | - | $631.31 M(+4.1%) |
| June 2023 | - | $606.60 M(+4.3%) |
| Mar 2023 | - | $581.48 M(+1.7%) |
| Dec 2022 | $571.72 M(-1.2%) | $571.72 M(-5.8%) |
| Sept 2022 | - | $606.93 M(+1.9%) |
| June 2022 | - | $595.68 M(+0.6%) |
| Mar 2022 | - | $591.89 M(+2.3%) |
| Dec 2021 | $578.53 M(+28.7%) | $578.53 M(-1.6%) |
| Sept 2021 | - | $587.96 M(+0.5%) |
| June 2021 | - | $584.77 M(+6.7%) |
| Mar 2021 | - | $548.00 M(+21.9%) |
| Dec 2020 | $449.39 M(+131.1%) | $449.39 M(+85.7%) |
| Sept 2020 | - | $242.01 M(-1.2%) |
| June 2020 | - | $244.86 M(+6.5%) |
| Mar 2020 | - | $229.89 M(+18.2%) |
| Dec 2019 | $194.50 M(+202.3%) | $194.50 M(+4.1%) |
| Sept 2019 | - | $186.76 M(+4.1%) |
| June 2019 | - | $179.48 M(+192.0%) |
| Mar 2019 | - | $61.47 M(-4.4%) |
| Dec 2018 | $64.33 M | $64.33 M(+52.1%) |
| Sept 2018 | - | $42.28 M(+20.9%) |
| June 2018 | - | $34.96 M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $30.05 M(-9.3%) |
| Dec 2017 | $33.14 M(+99.5%) | $33.14 M(-5.3%) |
| Sept 2017 | - | $35.00 M(+12.4%) |
| June 2017 | - | $31.14 M(+40.3%) |
| Mar 2017 | - | $22.19 M(+33.6%) |
| Dec 2016 | $16.61 M(+99.8%) | $16.61 M(+72.8%) |
| Sept 2016 | - | $9.61 M(+1.1%) |
| June 2016 | - | $9.51 M(+14.9%) |
| Mar 2016 | - | $8.28 M(-0.4%) |
| Dec 2015 | $8.31 M(-14.5%) | $8.31 M(-16.1%) |
| Sept 2015 | - | $9.91 M(-5.6%) |
| June 2015 | - | $10.50 M(-2.7%) |
| Mar 2015 | - | $10.79 M(+11.0%) |
| Dec 2014 | $9.72 M(+131.3%) | $9.72 M(-5.7%) |
| Sept 2014 | - | $10.31 M(-0.7%) |
| June 2014 | - | $10.38 M(+225.5%) |
| Mar 2014 | - | $3.19 M(-24.1%) |
| Dec 2013 | $4.20 M(-83.0%) | $4.20 M(+25.7%) |
| Sept 2013 | - | $3.34 M(-49.7%) |
| June 2013 | - | $6.64 M(+163.5%) |
| Mar 2013 | - | $2.52 M(-89.8%) |
| Dec 2012 | $24.70 M(+199.9%) | $24.70 M |
| Dec 2011 | $8.24 M(-35.0%) | - |
| Dec 2002 | $12.66 M(+6.9%) | - |
| Dec 2001 | $11.84 M(+16.3%) | - |
| Dec 2000 | $10.19 M(+96.5%) | - |
| Dec 1999 | $5.18 M | - |
FAQ
- What is Esperion Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Esperion Therapeutics?
- What is Esperion Therapeutics annual total liabilities year-on-year change?
- What is Esperion Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly total liabilities year-on-year change?
What is Esperion Therapeutics annual total liabilities?
The current annual total liabilities of ESPR is $660.79 M
What is the all time high annual total liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high annual total liabilities is $660.79 M
What is Esperion Therapeutics annual total liabilities year-on-year change?
Over the past year, ESPR annual total liabilities has changed by +$89.07 M (+15.58%)
What is Esperion Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ESPR is $684.32 M
What is the all time high quarterly total liabilities for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly total liabilities is $696.54 M
What is Esperion Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ESPR quarterly total liabilities has changed by +$53.01 M (+8.40%)